Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

With the advances of genetic knowledge, couples should take advantage of integrating genetic testing into their reproductive decisions and options.

Couples can now check their carrier risk in order to avoid passing on unobserved genetic conditions, if any, to the next generation, and for couples going through IVF (in vitro fertilization), they can check the aneuploidy status of embryos prior to implantation to enable greater success.

It’s about helping IVF parents become more knowledgeable, showing them the risks, and providing them options so they can make the best, most informed decisions for their families.

Laurie Seiwert knows all too well what it means to go through this journey. Luckily, she used PTG-A and carrier screening and is now a mother of a beautiful little boy.

Reproductive Health within Thermo Fisher Scientific provides a comprehensive genetic analysis solutions for the reproductive lifecycles, from carrier screening research to preimplantation genetic testing for aneuploidy (PGT-A) and single gene mutation (PGT-M), to prenatal and postnatal research, as well as diagnostic tools for the detection of CNVs associated with developmental delays and/or intellectual disability, congenital anomalies, and/or dysmorphic features.

The National Organization for Rare Disorders (NORD®) is celebrating Rare Disease Day 2021 with The Balancing Act.

Travis Flores is a 29-year-old cystic fibrosis survivor and a recipient of a very rare third double-lung transplant in May 2020.

The Balancing Act has partnered with the National Organization for Rare Disorders (NORD) and WEGO Health to shine a light on rare diseases and the impact they have on patients.

Comments

comments